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List of Abbreviations: 
SUDEP:  sudden unexpected death in epilepsy 
PACAP:  pituitary adenylate cyclase-activating polypeptide 
IML:  intermediolateral cell column 
RVLM:  rostral ventrolateral medulla 
SNA:  sympathetic nerve activity 
SE:  status epilepticus 
QT interval:  a measure of the time between the start of the Q wave and the end 
of the T wave in the heart's electrical cycle 
KA:  kainic acid 
TLE:  temporal lobe epilepsy 
Post-SE:  post-status epilepticus 
IT:  intrathecal 
ECG:  electrocardiogram 
O.D.:  outer diameter 
HR:  heart rate 
PBS:  phosphate-buffered saline 
TH:  tyrosine hydroxylase 
CD:  cluster of differentiation 
Iba1: iodinised calcium binding adaptor molecule-1 
AUC:  area under curve 
MAP:  mean arterial pressure 
PaCO2: partial pressure of carbon dioxide 
QTc:  corrected QT interval 
ir:  immunoreactive  
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Abstract: 
The incidence of sudden unexpected death in epilepsy (SUDEP) is highest in people 
with chronic and drug resistant epilepsy. Chronic spontaneous recurrent seizures 
cause cardiorespiratory autonomic dysfunctions. Pituitary adenylate 
cyclase-activating polypeptide (PACAP) is neuroprotective, whereas microglia 
produce both pro- and anti- inflammatory effects in the CNS. During acute seizures in 
rats, PACAP and microglia produce sympathoprotective effect at the 
intermediolateral cell column (IML), whereas their action on the presympathetic 
rostral ventrolateral medulla (RVLM) neurons mediates proarrhythmogenic changes. 
We evaluated the effect of PACAP and microglia at the IML on sympathetic nerve 
activity (SNA), cardiovascular reflex responses, and electrocardiographic changes in 
the post-status epilepticus (SE) model of acquired epilepsy, and control rats. Chronic 
spontaneous seizures in rats produced tachycardia with profound proarrhythmogenic 
effects (prolongation of QT interval). Antagonism of microglia, but not PACAP, 
significantly reduced the SNA and the corrected QT interval in post-SE rats. PACAP 
and microglia antagonists did not change baroreflex and peripheral or central 
chemoreflex responses with varied effect on somatosympathetic responses in post-
SE and control rats. We did not notice changes in microglial morphology or changes 
in a number of M2 phenotype in epileptic nor control rats in the vicinity of RVLM 
neurons. Our findings establish that microglial activation, and not PACAP, at the IML 
accounts for higher SNA and proarrhythmogenic changes during chronic epilepsy in 
rats. This is the first experimental evidence to support a neurotoxic effect of microglia 
during chronic epilepsy, in contrast to their neuroprotective action during acute 
seizures. 
Keywords: 
Microglia, Sympathoexcitation, Temporal lobe epilepsy, Rats, Proarrhythmogenic, 
PACAP 
  
5 
 
Introduction: 
Epilepsy is a chronic brain disorder characterised by spontaneous recurrent seizures 
and carries a risk of sudden death that is 15-20 times higher than in normal 
population (Ficker et al., 1998; Nilsson et al., 1999; Eastaugh et al., 2015). Epilepsy 
affects about 50 million people worldwide (WHO, 2005); seizures can range from 
brief, barely noticeable loss of attention to major convulsions that affect the entire 
neuraxis. Epilepsy is associated with changes in autonomic functions, such as 
sympathovagal imbalance, sympathetic reflex dysfunction, tachycardia with 
concomitant arrhythmia or bradycardia with associated apnoea (Dütsch et al., 2006; 
Bateman et al., 2008; Ponnusamy et al., 2012; Massey et al., 2014; Powell et al., 
2014b; Bhandare et al., 2015; Bhandare et al., 2016a). Seizure associated 
autonomic cardiorespiratory changes are well-documented and are thought to play 
an important role in a mechanism of sudden unexpected death in epilepsy (SUDEP) 
(Nei et al., 2004; Dlouhy et al., 2015). Interictal autonomic changes are also seen in 
patients with chronic epilepsy (Ansakorpi et al., 2000; Berilgen et al., 2004; Müngen 
et al., 2010; Lotufo et al., 2012). Nevertheless, the neuronal mechanisms causing 
autonomic cardiorespiratory dysfunction during chronic epilepsy are unknown. 
Pituitary adenylate cyclase-activating polypeptide (PACAP), a 38 amino acid 
pleiotropic neuropeptide, produce neuroprotective effects (Shioda et al., 1998; Ohtaki 
et al., 2006; Bhandare et al., 2015) that are partly mediated through its action on 
microglia (Wada et al., 2013; Brifault et al., 2015). PACAP and microglia have a 
protective effect on sympathetic preganglionic neurons at the intermediolateral cell 
column (IML), where they ameliorate the sympathoexcitatory effect of acute seizures 
(Bhandare et al., 2015). During acute seizures, PACAP and microglia act on 
presympathetic rostral ventrolateral medulla (RVLM) neurons in the brainstem to 
promote proarrhythmogenic changes, but not sympathoexcitation (Bhandare et al., 
2016a). In many cardiovascular autonomic nuclei PACAP is pressor and 
sympathoexcitatory (Farnham et al., 2008; Farnham et al., 2011; Inglott et al., 2011) 
and changes baroreflex response in trout (Lancien et al., 2011) but not in rats 
(Farnham et al., 2012). PACAP expression is increased in central autonomic nuclei 
(paraventricular nucleus) after kainic acid (KA)-induced seizures in rats (Nomura et 
al., 2000). Secondly, seizures produce microglial activation, and neuroinflammation 
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in patients and animal models (Beach et al., 1995; Shapiro et al., 2008; Eyo et al., 
2014), which persist for many years during chronic epilepsy (Beach et al., 1995; 
Papageorgiou et al., 2015). Microglia can be pro- or anti- inflammatory in animal 
models of temporal lobe epilepsy (TLE) (Shapiro et al., 2008; Mirrione et al., 2010; 
Vinet et al., 2012; Devinsky et al., 2013). Although the pro- or anti- inflammatory state 
of activated microglia is a topic of debate, there is strong support for their dual role 
(Hanisch and Kettenmann, 2007). Short term microglial activation is considered 
beneficial (Mirrione et al., 2010; Vinet et al., 2012; Szalay et al., 2016), whereas 
chronic microglial activation is deleterious, and produces a damaging response to 
injury (Qin et al., 2007; Loane et al., 2014; Olmos-Alonso et al., 2016). During KA-
induced acute seizures, spinal microglia have a protective effect on sympathetic 
preganglionic neurons (Bhandare et al., 2015), however, their role in chronic epilepsy 
is not known.  
Thus, the aims of this study were to identify the role of PACAP and microglia in the 
spinal cord, during chronic epilepsy, in the regulation of central autonomic 
cardiovascular activity. To achieve these aims we used a model of acquired epilepsy 
in rats that manifest spontaneous seizures and many features of acquired epilepsy in 
humans– the KA-induced post-status epilepticus (post-SE) model (Morimoto et al., 
2004; Powell et al., 2008; Jupp et al., 2012). The effect of intrathecal (IT) infusion of 
the PACAP antagonist, PACAP(6-38), and the microglial antagonist, minocycline, on 
sympathetic activity, cardiovascular reflex responses, and the electrocardiogram 
(ECG) were analysed in chronically epileptic and control rats. Microglial morphology 
and their phenotype in the vicinity of RVLM neurons were analysed with 
immunohistochemistry in epileptic and control rats. 
Experimental Procedures: 
Animals 
The animal usage and protocols were in accordance with the Australian code of 
practice for the care and use of animals for scientific purposes. The protocols were 
approved by the Animal Care, and Ethics Committee of Macquarie University, The 
University of Melbourne, and the Sydney Local Health District. The epilepsy surgery 
and procedures were performed under isoflurane anesthesia on 17-19 weeks old 
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adult non-epileptic control (n = 9), and post-SE (n = 15) male Wistar rats, whereas 
electrophysiology experiments were performed under urethane anesthesia. 
KA-induced post-SE rat model  
The post-SE model of acquired epilepsy was generated by i.p. injection of the 
glutamate receptor agonist, KA, to induce a period of continuous seizure activity 
(status epilepticus) in non-epileptic rats as described previously (Hellier et al., 1998; 
Powell et al., 2008; Jupp et al., 2012; Powell et al., 2014b; Vivash et al., 2014). 
Twelve week old Wistar rats were injected with repeated low doses of KA (5mg/kg, 
i.p., followed by 2.5 mg/kg, i.p., injections once per hour) until SE behaviour was 
observed. After four hours of SE, all rats were given diazepam injection (5mg/kg i.p.) 
to terminate the SE. Rats were then returned to their home cages in the animal 
house and maintained with normal animal house care and diet. 
Implantation of EEG-ECG electrodes in post-SE and control rats 
Seven weeks after KA-induced SE (n = 15) (or saline administered controls (n = 9)), 
two ECG electrodes and four EEG electrodes were implanted in each rat under 
isoflurane anesthesia (5% during induction, 2.5-1.5% for maintenance) in oxygen (2.0 
L/min during induction, 0.5-1.0 L/min for maintenance) as detailed in supporting data 
by (Powell et al., 2014b). Two small incisions were made to expose the thoracic 
muscle directly above the heart, and to expose the muscle overlying the xiphoid 
process of the sternum. The distal end of an ECG lead (13 cm; PlasticsOne, USA) 
was sutured to each muscle using polypropylene, 4-0 (Sharpoint, USA). The leads of 
both ECG electrodes were then tunnelled up through the left side of the neck 
subcutaneously, and the skin layer was sutured (polyglycolic, 4-0; LOOK™, USA). A 
single midline incision was then made on the scalp to expose the skull. Two ECG 
leads were located and tunneled through the neck to allow protrusion of the leads out 
of the incision site on the scalp. Each rat was then placed into a stereotaxic frame, 
and four extradural electrodes comprised of gold-plated sockets attached to stainless 
steel screws (O.D. 1 mm; Plastics One, USA) were implanted into the skull: one on 
each side approximately 2 mm from the midline, 3 mm anterior to the Bregma, one at 
approximately the centre of the midline, and another 6 mm posterior to the Bregma, 4 
mm right of the midline. The electrodes were fixed to the skull using dental cement 
(Vertex-Dental, The Netherlands), and the animals observed until recovery. 
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In vivo EEG-ECG recordings 
One week after recovery from the surgery, a continuous 24 h video-EEG-ECG 
recording was acquired for one week using Compumedics EEG acquisition software 
(Profusion EEG 4 v4.3, Australia) digitised at 2048Hz as previously described 
(Powell et al., 2008; Powell et al., 2014b). Each recording was reviewed for seizure 
activity, and the start and end of a seizure was manually marked on the EEG to allow 
quantification of the number of seizures and seizure duration. Seizure activity on the 
EEG was defined as per our previous work, and that of others, as the development of 
high-amplitude, rhythmic discharges that clearly represented a new pattern of tracing 
(Kharatishvili et al., 2006; Bouilleret et al., 2011). This included repetitive spikes, 
spike-and-wave discharges, and slow waves. The event must have lasted at least 5 s 
and showed an evolution in the dominant frequency, and be accompanied by 
behavioural change observable on the video recording consistent with a seizure. 
Normally, all post-SE rats develop spontaneous seizures, and none were observed in 
control rats. 
Non-invasive tail-cuff blood pressure recordings 
A week after confirmation of spontaneous recurrent seizures in post-SE rats with 
video-EEG recordings and in age-matched controls, blood pressure was recorded 
with a non-invasive tail-cuff method (IITC Life Sciences Inc., California, USA) 
(Farnham et al., 2011). Rats were placed in an animal holder, pre-warmed at 320C, 
and acclimatised to the chamber. All animals were kept in the chamber for 10-15 min; 
a cuff was attached to their tail, and blood pressure was recorded in triplicate and 
averaged. Heart rate (HR) and systolic, diastolic, and mean blood pressure was 
derived from the blood pressure waveform channel. 
In vivo electrophysiology 
General surgical procedure: Electrophysiology surgical procedures were carried 
out as described previously (Bhandare et al., 2015). Briefly, rats (n = 24) were 
anesthetised with intraperitoneal injection of 10% urethane (ethyl carbamate; 1.3–1.5 
g/kg; Sigma-Aldrich). The depth of anaesthesia was controlled by periodic tail/paw 
pinches and observing reflex responses (withdrawal or pressor >10 mmHg). When 
reflex responses were observed, an additional anaesthetic was injected (30-40 mg, 
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10% urethane intravenous). Bronchial secretion was prevented through 
administration of atropine sulphate (100 µg/kg, i.p.; Pfizer (Perth) Pty Limited, WA, 
Australia) with the first dose of anaesthetic.  
The jugular vein and right carotid artery were cannulated for the administration of 
drugs and fluids, and for the recording of blood pressure, respectively. Tracheostomy 
enabled a mechanical ventilation. ECG was recorded through three lead electrodes, 
where two silver electrodes were inserted into the front paws and ground electrode 
into the exposed muscle on the back of rat. HR was derived from the peak of the R 
wave and drawn as an event channel. The head mounted EEG electrodes for in vivo 
EEG-ECG recordings enabled the recording of EEG signal. After bilateral cervical 
vagotomy rats were artificially ventilated (Ugo Basile, Italy) with 100% oxygen in 
order to silence the peripheral chemoreceptors. Rats were paralysed with 
pancuronium bromide (0.4 mg given as a 0.2 ml bolus i.v. injection) followed by an 
infusion of 10% pancuronium in 0.9% saline at a rate of 2 ml/h for the duration of the 
experiment. Rats were then secured in a stereotaxic frame and body temperature 
was maintained between 36.5 and 37.50C until the end of experiment with the use of 
a rectal probe and a homeothermic blanket (TC-1000; CWE). Arterial blood gases 
and electrolytes were analysed with an electrolyte and blood gas analyser (IDEXX 
Vetstat, West Brook, USA), and pH was maintained between 7.35 - 7.45 and PaCO2 
at 40 ± 2. 
IT catheter placement: The muscle layer attached to the occipital bone was 
carefully scraped with the cotton swabs to expose the membrane over the 
atlanto-occipital junction. The slit was made through the membrane and the surge of 
cerebrospinal fluid (CSF) provided the confirmation of correct site and was stopped 
by holding dry cotton swab. A polyethylene tubing (O.D. = 0.50 mm; I.D. = 0.20 mm; 
Microtube Extrusions Pty Ltd, NSW, Australia) with a dead space of ~6 µl was 
inserted through a slit in the dura into the IT space of all rats and advanced caudally 
to the level of T5/6. 
IT drug administration protocol: In all groups, drugs were administered 
intrathecally 10 min after recording of baseline reflex responses and flushed in with 
6µl of phosphate-buffered saline (PBS). In both post-SE (n = 5) and control (n = 3) 
rats, 10 µl of a control injection of 10 mmol/l PBS, 1 mmol/l PACAP(6-38) or 
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100µg/10µl minocycline was administered intrathecally. All infusions were made over 
a 10 to 15 s period, as previously described (Bhandare et al., 2015). 
Isolation and preparation of nerves: The procedures were performed as described 
previously (Abbott and Pilowsky, 2009; Farnham et al., 2011; Inglott et al., 2011; 
Shahid et al., 2011). The left phrenic nerve and the left greater splanchnic 
sympathetic nerve at a site proximal to the coeliac ganglion were isolated and 
dissected. The dissected nerves were cut and the distal ends were tied with 5/0 silk 
thread. The isolated phrenic and splanchnic nerves were placed across a bipolar 
stainless steel electrodes and recorded. The nerves were electrically isolated either 
with paraffin oil or silgel. Signals were amplified (CWE, Incorporated, BMA-931 
Bioamplifiers) (sampling rate: 6 kHz, gain: 2,000, filtering: 30-3,000Hz) and noise 
was removed with a 50/60-Hz line frequency filter (Humbug; Quest Scientific). The 
sciatic nerve was isolated at the mid-thigh, tied with 5/0 silk thread, and cut distally. 
The left aortic depressor nerve was isolated from the cervical vagus nerve at the 
level of the carotid bifurcation, tied with 5/0 silk thread and cut close to the chest. 
Aortic depressor and sciatic nerve stimulation and chemoreflexes protocol: 
The effect of aortic depressor and sciatic nerve stimulation on splanchnic 
sympathetic nerve activity (SNA) was assessed to estimate the baroreflex and 
somatosympathetic reflex function in post-SE and control rats in described previously 
(Miyawaki et al., 2001; Abbott and Pilowsky, 2009). Stimuli were generated by 
isolated stimulators controlled by a Spike2 script (version 8.03; Cambridge Electronic 
Design). Stimulus threshold was determined by increasing or decreasing the stimulus 
voltage until no response was observed. During each experimental protocol, the 
aortic depressor nerve was stimulated at 4 times threshold (1-10 V, 0.2-ms pulse 
width, 100 cycles at 1 Hz across 100 s), and the average SNA response was 
analysed before, and 60, 90 and 120 min after IT treatment (Fig. 1). The left sciatic 
nerve was stimulated to generate the somatosympathetic response. Stimulus 
threshold was determined as described above, and sciatic nerve was stimulated at 4 
times threshold (1-5 V, 0.2 ms pulse width, 100 pulses at 0.4 Hz across 250 s), and 
the average response of SNA was analysed before, and 60, 90 and 120 min after IT 
treatment (Fig. 1).  
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Peripheral chemoreceptors were stimulated by ventilating animals with 10% O2 in N2 
for 45 sec (Abbott and Pilowsky, 2009). Central chemoreceptors were stimulated by 
ventilating animals with 5% CO2 / 95% O2 for 3 min (Abbott and Pilowsky, 2009). The 
observed reflex responses are generated due to stimulation of central 
chemoreceptors as oxygenation of the blood was maintained throughout the 
challenge. Both the central and peripheral chemoreflex responses were generated 
prior to, and at 60 and 120 min after IT treatment (Fig. 1). 
Collection of blood and plasma samples and catecholamine analysis: At the 
conclusion of the electrophysiology experiments, 3-4 ml blood was withdrawn from 
the carotid artery and collected in heparinised tubes containing metabisulphite. Blood 
samples were immediately centrifuged at 40C for 10 min at 900g and plasma 
collected and stored at -200C until analysis. Plasma adrenaline and noradrenaline 
were extracted onto activated alumina, eluted, and analysed with reverse phase 
HPLC and electrochemical detection. 
Histology 
Perfusions: One millilitre of heparin was injected in each rat through the venous line 
at the conclusion of the electrophysiology experiments, and then rats were perfused 
transcardially with 400 ml of ice-cold 0.9% saline followed by 400 ml of 4% 
paraformaldehyde solution. Brains were removed and post-fixed in the same fixative 
for 18-24 h. 
Sectioning and immunohistochemistry: Immunohistochemical analysis was done, 
as described previously (Bhandare et al., 2016a; Kapoor et al., 2016c), in n = 3 rats 
from both post-SE and control groups treated with IT PBS. Brainstems were 
sectioned coronally (40 µm thick) with a vibrating microtome (Leica, VT1200S). 
Sections were sequentially collected into five different pots containing a 
cryoprotectant solution, and stored at -200C until further processing. Histological 
procedures were performed on free-floating sections. Sections were rinsed, blocked, 
and incubated in primary antibodies for 48 h: rabbit anti-CD206 (1:2,000; Abcam, 
Melbourne, Victoria, Australia), goat anti-Iba1 (1:1,000; Novus Biologicals, Littleton, 
Colorado, USA) and mouse anti-tyrosine hydroxylase (TH) (1:100; Avanti Antibodies; 
(Nedoboy et al., 2016)). Sections were rinsed and CD-206 (cluster of differentiation 
(CD)-206 is a mannose receptor present on M2 phenotype of microglia), Iba1 
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(iodinised calcium binding adaptor molecule-1; a microglia/macrophage specific 
calcium binding protein) and TH (C1 neurons) immunoreactivity was subsequently 
revealed by overnight incubation with the following secondary antibodies at 1:500 
dilutions (Jackson Immunoresearch Laboratories, West Grove, Pennsylvania, USA): 
Alexa Fluor 488-conjugated donkey anti-rabbit, Cy3-conjugated donkey anti-goat, 
and Cy5-conjugated donkey anti-mouse,. Sections were rinsed, mounted 
sequentially on glass slides, and coverslipped with Vectashield (Vector Laboratories, 
Burlingame, California, USA). 
Data acquisition and analysis 
Electrophysiology data: Data were acquired using a Spike2 acquisition and 
analysis software (version 8.06; Cambridge Electronic Design), and CED 1401 ADC 
system (Cambridge Electronic Design). The EEG data were recorded, amplified 
(CWE, Incorporated, BMA-931 Bioamplifier), band-pass filtered from 1 Hz to 10 kHz, 
and digitised at 20 kHz with a 100x gain. The EEG raw signal was DC removed and 
the “gamma” frequency range (25-45 Hz) was analysed, as shown previously 
(Bhandare et al., 2016a). The EEG “gamma” frequency range was analysed from 5 
min blocks taken 1 min before IT treatment and 60 and 120 min post-treatment. The 
EEG data was also manually analysed in a blinded manner for detection of seizure 
activity as explained above. Phrenic nerve activity was rectified and smoothed (τ 0.5 
s), and analysed from 1-min blocks taken 1 min before, and 60 and 120 min after IT 
treatment. The phrenic nerve activity area under curve (AUC) was analysed at 60 
and 120 min after IT treatment. The percent change in the AUC at 60 and 120 min 
were compared with the pre-treatment area that was considered as 100%. SNA was 
rectified and smoothed (τ 2 s), and normalized to zero by subtracting the residual 
activity 5-10 min after death or after nerve pinch. The integrated SNA trace was 
calibrated (baseline as 100% and death level as 0%) and analysed for AUC between 
60 to 120 min after IT PBS, PACAP(6-38) or minocycline infusion. Mean arterial 
pressure (MAP) and HR were analysed from 1-min blocks taken 1 min before, and 
30, 60, 90 and 120 min after IT infusion (only 120 min results are shown in graphs). 
Baroreflex and somatosympathetic reflex responses were analysed before, and 60, 
90 and 120 min after IT treatment (Fig. 1). The percent change in baroreflex 
response (AUC) was calculated considering pre-treatment response as 100%. The 
somatosympathetic reflex response was analysed with a sigmoid curve fit analysis. A 
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sigmoid curve was fitted to averaged waveform of somatosympathetic response 
curve (both fast conducting A-fibre and slow conducting C-fibre response). The low, 
high, range, and slope values were calculated (only range is shown in the graph). 
The pre-treatment range is considered as 100% response, and percent change is 
calculated at 60, 90 and 120 min post-treatment. Peripheral and central chemoreflex 
responses were analysed as percent change in the SNA AUC at 60 and 120 min 
post-treatment compared to the pre-treatment response (considered as 100%). 
Core body temperature, and end-tidal CO2 were analysed from 1-min blocks taken 1 
min before and 30, 60, 90, and 120 min after IT injection. In all animals, arterial blood 
gas levels (PaCO2) and pH were measured 10 min before the start of the protocol, 
and 120 min after IT treatment. Statistical analysis was carried out in GraphPad 
Prism software (version 6.05). Statistical significance was determined using one-way 
ANOVA followed by t-tests with the Holm-Šídák correction. Multiple comparisons 
were done between groups. p ≤ 0.05 was considered significant. 
Calculation of corrected QT (QTc) interval: ECG raw data was processed (DC 
remove), wherever baseline fluctuations were prominent. QT, PR, and RR intervals 
were analysed from the ECG recordings. Bazett formula was used for calculation of 
QTc interval, where the QT interval in seconds was divided by the square root of the 
R-R interval in seconds (Bazett, 1920). The QTc was obtained before, and 120 min 
after IT injection. The QTc and PR interval statistical analysis was carried out in 
GraphPad Prism software (version 6.05). Statistical significance was determined 
using one-way ANOVA between treatment groups followed by t-tests with the Holm-
Šídák correction. Multiple comparisons were done between groups. p ≤ 0.05 was 
considered significant. 
Histology imaging and analysis: Acquisition and analysis of histology images is 
performed as described previously (Bhandare et al., 2016a; Kapoor et al., 2016b; 
Kapoor et al., 2016c). In brief, all images were acquired, at 20X and 40X 
magnifications, using a Zeiss Axio Imager Z2 (Zeiss, Germany). A 0.16 mm2 box was 
then placed within the imaged RVLM, and this area was used for analysis. The 
branch length and a number of endpoint processes of Iba1-labelled microglial cells in 
the vicinity of TH-labelled RVLM neurons was analysed using ImageJ plugin 
software. Statistical analysis was carried out using GraphPad Prism (version 6.05) for 
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chi-square test for goodness of fit. The proportions of CD206 labelled anti-
inflammatory M2 microglia in the RVLM of post-SE rats were compared with control 
group. Statistical significance was determined using non-parametric Mann-Whitney 
test (Sokal and Rohlf, 2012).  
Results: 
Development of spontaneous recurrent seizures in post-SE rats 
A typical spontaneous recurrent seizure with transition into ictal period is shown in 
Fig. 2, which is characterised by high-amplitude and showed a clear new pattern of 
tracing. Video-EEG-ECG recordings confirmed that 9 weeks after induction of KA-
induced SE, almost all rats developed spontaneous recurrent seizures with 0.44 ± 
0.07 seizures per day (range 0-3) and with duration of 19.7 ± 3.3 sec per day 
(Table 1). The seizure frequency and scores are highly variable across the post-SE 
rats as shown in Table 1. Whilst some of the post-SE animals may not have had 
seizures during recording period (a week), and is just could be due to the low 
frequency. None of the control rats (saline treatment) developed spontaneous 
seizures.  
Chronic seizure-induced tachycardia and HR variability changes 
The in vivo EEG-ECG recordings in conscious chronic epileptic rat revealed that 
spontaneous seizure causes a dramatic tachycardia (~500 bpm (beats per minute) 
compared with ~300 bpm during pre-ictal period; Fig. 3A) and was characterised by a 
significant variability. The HR variability was increased from 91.8% to 98.2% in post-
ictal period (Fig. 3B-E). HR was significantly unstable for more than one hour after 
the spontaneous seizure. These changes would contribute to the development of 
unstable, and possibly lethal cardiovascular abnormalities. 
MAP, HR and plasma catecholamines in post-SE and control rats  
Non-invasive tail-cuff blood pressure measurements confirmed that there were no 
significant differences in MAP and HR interictally between post-SE (n = 15), and 
control (n = 9) rats (Table 2). The MAP was 125.8 ± 4.5 mmHg in post-SE rats 
compared to 129.3 ± 3.9 mmHg in controls (Table 2). Moreover, the systolic and 
diastolic blood pressure values were not significantly different between these two 
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groups (data not shown). The HR was 310 ± 8 bpm and 326 ± 10 bpm in post-SE 
and control rats, respectively (Table 2). Plasma catecholamine levels (adrenaline and 
noradrenaline) were also not significantly different between the groups. The plasma 
adrenaline was 1.6 ± 0.3 nmol/L and 1.9 ± 0.5 nmol/L in post-SE and control rats, 
respectively (Table 2). The noradrenaline concentration was also similar in both 
groups of rats; 3.4 ± 0.5 nmol/L in post-SE, and 3.9 ± 0.8 nmol/L in controls (Table 2). 
Inhibition of microglial activation, but not PACAP, attenuates higher SNA and 
proarrhythmogenic changes in rats with spontaneous recurrent seizures 
Our results showed that in chronically epileptic post-SE rats, the antagonism of 
microglial activation with minocycline at IT level significantly reduced SNA (∆ -25.0 ± 
10.0%; p ≤ 0.05) compared to PBS-treated group (∆ 10.0 ± 7.7%) (Fig. 4AI). More 
interestingly, IT minocycline treatment in control rats (∆ -17.1 ± 18.5%) has a similar 
effect to PBS-treated control rats (∆ -17.8 ± 19.8%) (Fig. 4BI). IT PACAP(6-38) does 
not affect SNA activity in post-SE rats (∆ -15.3 ± 10.1%) compared with PBS 
treatment (Fig. 4AI). Similar results were obtained in control rats where changes in 
SNA were non-significant in IT PACAP(6-38) (∆ -18.5 ± 8.1%), and PBS treatments 
(Fig. 4BI). MAP and HR remained unchanged in both post-SE, and control rats 
treated with IT PBS, PACAP antagonist, and microglia antagonist (Figs. 4AII-III and 
4BII-III). In post-SE rats, the HR changes were similar in PBS (∆ 0 ± 9 bpm), 
PACAP(6-38) (∆ -8 ± 5 bpm) and minocycline (∆ 1 ± 8 bpm) treated rats (Fig. 4AIII). 
There was a similar pattern in control rats (Fig. 4BIII) treated with PBS (∆ 3 ± 14 
bpm), PACAP(6-38) (∆ 7 ± 10 bpm) and minocycline (∆ 1 ± 7 bpm). MAP was found 
to be unaltered in post-SE (Fig. 4AII) and control groups of rats (Fig. 4BII) treated 
with PBS (∆ 0.0 ± 2.0 mmHg and ∆ 6.5 ± 4.3 mmHg, respectively), PACAP(6-38) (∆ 
1.3 ± 6.7 mmHg and ∆ 4.7 ± 1.4 mmHg, respectively), and minocycline (∆ -4.3 ± 4.2 
mmHg and ∆ 13.7 ± 8.4 mmHg, respectively). 
The ECG findings in post-SE rats treated with IT minocycline showed a reduction in 
QTc interval duration (Figs. 5AI, 5CIII). In post-SE rats, the QTc interval was 
significantly reduced at 120 min after minocycline treatment compared to the pre-
treatment period (∆ -3.0 ± 0.5 ms; p ≤ 0.05). The representative Poincare plot (Fig. 
5CIII) clearly shows that IT minocycline treatment significantly reduced the QT 
interval. At 120 min post-treatment, the QTc interval in IT PBS and PACAP(6-38) 
  
16 
 
treated groups did not change compared to the pre-treatment period (∆ 1.7 ± 1.1 ms 
and ∆ 0.5 ± 1.3 ms, respectively; Fig. 5AI) (representative Poincare plot Fig. 5CI-II). 
In control rats, none of the treatments (IT PBS, PACAP(6-38) or minocycline) had a 
significant effect on QTc interval (Fig. 5BI). The IT PBS, PACAP(6-38) and 
minocycline do not alter the PR interval values in post-SE and control rats (Figs. 5AII 
and 5BII). 
We did not observe any changes in EEG activity, phrenic nerve activity, expired CO2 
or body temperature in any of the groups (results not shown). EEG data during 
electrophysiology experiments revealed that none of the post-SE or control rats had 
spontaneous seizures under anaesthetised experimental conditions. Blood gas 
analysis confirmed that PaCO2 and pH were within the normal physiological range 
(PaCO2 was 40 ± 2 and pH between 7.35-7.45) throughout the experiments. 
Neither microglia nor PACAP antagonists alter baroreflex, peripheral or central 
chemoreflex responses in epileptic post-SE or control rats, with varied effects 
on somatosympathetic responses 
A typical cardiovascular reflex response is shown in Figure 1A. The protocol involved 
stimulation of aortic depressor nerve (baroreflex; Fig. 1B), stimulation of sciatic nerve 
(somatosympathetic; Fig. 1C), peripheral chemoreflex (Fig. 1D) and central 
chemoreflex responses (Fig. 1E), which were repeated at 60 and/or 90 and 120 min 
after IT treatment. Baroreflex responses were unaffected with the antagonism of 
PACAP or microglia in both post-SE, and control rats at 60 min, 90 min, and 120 min 
post-treatment (Figs. 6AI and 6BI). 120 min after IT treatments, the %∆ AUC of 
baroreflex response was unchanged in post-SE rats and control rats treated with 
PBS (∆ 0.6 ± 1.7% and ∆ 3.1 ± 0.3%, respectively), PACAP(6-38) (∆ 2.0 ± 7.9% and 
∆ -1.0 ± 0.5%, respectively), and minocycline (∆ 1.3 ± 2.6% and ∆ 1.3 ± 1.5%, 
respectively).  
The IT treatments in both post-SE and control rats produced varied effects on 
somtosympathetic reflex responses (Figs. 6AII-III and 6BII-III). Stimulation of sciatic 
nerve in post-SE rats treated with PBS showed significant decrease in fast (A-fibre; 
Fig. 6AII), and slow (C-fibre; Fig. 6AIII) conducting nerve fibre somatosympathetic 
responses over the time course (∆ -36.0 ± 8.3% and ∆ -53.6 ± 14.3%, respectively at 
120 min; p ≤ 0.05). In post-SE rats, the A- and C-nerve fibre somatosympathetic 
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responses were unaffected by IT PACAP(6-38) (∆ -29.8 ± 17.5% and ∆ -40.8 ± 
18.4%, respectively at 120 min) and minocycline (∆ -37.4 ± 16.3% and ∆ -43.8 ± 
21.9%, respectively at 120 min) treatment (Figs. 6AII-III). At 60, 90 and 120 min post-
treatment, the fast conducting A-fibre somatosympathetic response was decreased in 
control rats treated with minocycline (∆ -61.0 ± 9.9%, at 120 min; p ≤ 0.001; Fig 6BII), 
whereas slow conducting C-fibre response was significantly reduced in rats treated 
with IT PBS (∆ -55.2 ± 9.6%, at 120 min; p ≤ 0.001) and PACAP(6-38) (∆ -49.0 ± 
3.1%, at 120 min; p ≤ 0.01) (Fig. 6BIII).  
The peripheral and central chemoreflex responses in post-SE, and control rats 
treated with IT PBS, PACAP(6-38), and minocycline were not altered at 60 or 120 
min post treatment (Fig. 7). In post-SE rats, peripheral (Fig. 7AI) and central (Fig. 
7AII) chemoreflex responses were unchanged in IT PBS (∆ 2.5 ± 10.0% and ∆ 13.3 ± 
3.7%, respectively), IT PACAP(6-38) (∆ 3.9 ± 3.7% and ∆ -1.1 ± 3.1%, respectively), 
and IT minocycline (∆ 5.8 ± 2.9% and ∆ 1.9 ± 3.3%, respectively) treated groups. The 
similar trend was noted in control rats where change in peripheral (Fig. 7BI) and 
central (Fig. 7BII) chemoreflex responses were ∆ 3.7 ± 1.4% and ∆ 3.2 ± 1.1% in IT 
PBS groups, respectively, ∆ 5.7 ± 4.8% and ∆ -10.8 ± 10.3% in IT PACAP(6-38) 
groups, respectively, and ∆ 8.8 ± 10.0% and ∆ 6.1 ± 1.8% in minocycline-treated 
groups, respectively. 
During spontaneous recurrent seizures, microglia are in surveillance state in 
the vicinity of the RVLM neurons  
The morphological analysis of microglia was carried out in post-SE and control rats 
(n = 3) in the vicinity of the RVLM neurons. The brainstem sections that contain TH-
immunoreactive (ir) RVLM neurons, were labelled with CD206-ir labelled anti-
inflammatory M2 phenotype of microglia, and Iba1, which is a marker for all 
microglia. The morphological analysis demonstrated that TH-ir neurons were 
surrounded with typical resting microglial cells in both groups (Fig. 8A-B). In both 
groups microglia appeared with a round cell body, and normal long processes with 
few ramifications (Fig. 8A-B). Total number of microglia in each group are shown in 
Table 3. Activated microglia were identified with the analysis of branch length and a 
number of endpoint processes. Mean branch length and a number of endpoint 
processes of Iba1 labelled microglia were not significantly different between vehicle 
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control and epileptic rats (Table 3). The proportion of anti-inflammatory M2 
phenotype of microglia was 12.91 ± 3.95% in post-SE rats, which was similar in 
controls (8.89 ± 2.14%; Table 3). These findings revealed that microglia are in a 
surveillance state and there are no differences in their morphology and proportion of 
M2 phenotype, at least in the RVLM, between epileptic and control groups.  
Discussion: 
The study provides direct evidence that microglia play a role in mediating increased 
SNA, and arrhythmogenic cardiac electrophysiological changes in chronic epileptic 
rats. First, spontaneous seizures cause severe tachycardia with prolongation of QT 
interval that persisted for more than one hour after the onset of a seizure. Secondly, 
antagonism of microglial activation, but not PACAP, in the spinal cord significantly 
reduces the SNA and seizure-induced prolongation of QTc interval in epileptic rats. 
Control groups showed no significant changes, however large variations could be 
attributed to sample size. Thirdly, neither spinal PACAP nor microglia regulate 
baroreflex or peripheral and central chemoreflex responses in epileptic and control 
rats, whereas PACAP or microglia antagonist decreases either A- or C-fibre 
somatosymapthetic response in control rats and has no effect in post-SE rats. 
Fourthly, interictally epileptic rats, and controls, were normotensive with the plasma 
catecholamine levels in a normal range. Finally, our findings show that 
morphologically, microglia were in a surveillance stage in chronically epileptic rats 
with no difference in the number of a M2 phenotype compared with controls. 
Microglia are the resident immune cells of the CNS, contributing ~10% of the total 
brain cell population. They respond to all types of pathological stimulus, including 
seizures, through activation, and adoption of either a ‘pro-inflammatory M1’ or ‘anti-
inflammatory M2’ phenotype (Li et al., 2007; Lai and Todd, 2008; Loane and Byrnes, 
2010; Kapoor et al., 2016a). Epileptic seizures cause extensive microglial activation 
in patients (Beach et al., 1995), and in animal models (Drage et al., 2002), but there 
is a considerable controversy surrounding the pro- (Shapiro et al., 2008) or anti- 
inflammatory (Mirrione et al., 2010; Eyo et al., 2014) role of microglia during and 
following a seizure. Previous findings demonstrated that during acute seizures, 
microglia protect sympathetic preganglionic neurons from excitotoxicity (Bhandare et 
al., 2015). Our current findings show that the SNA and prolongation of QTc interval 
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following spontaneous seizures were significantly reduced in epileptic rats, when the 
microglial activation was inhibited at the IML. These novel findings strengthen the 
concept that during chronic pathological insult, such as spontaneous recurrent 
seizures, maladaptive responses of microglia may lead to a “deleterious” activation 
state (M1) that triggers the release of pro-inflammatory cytokines such as IL-1β and 
TNFα (Benson et al., 2015), in contrast to their beneficial activation during acute 
insult (Fig. 9). This concept has been proposed by others (Hanisch and Kettenmann, 
2007; Gao et al., 2011; Eyo et al., 2017), and is supported by previous studies 
(Bhandare et al., 2015; Olmos-Alonso et al., 2016). During acute seizure, microglia 
can acquire a “beneficial” activation state (M2) to protect an overexcited neurons, 
and restore the normal homeostatic condition to limit the further damage (Fig. 9), 
whereas pharmacological targeting of colony-stimulating factor 1 receptors during 
late (chronic) phase in transgenic mice inhibits microglial proliferation and prevents 
the progression of Alzheimer’s-like pathology (Olmos-Alonso et al., 2016). 
Minocycline inhibits p38 mitogen-activated protein kinase and acts as a microglia 
antagonist (He et al., 2001; Tikka et al., 2001; Ueno et al., 2013). Minocycline does 
not produce significant effect on the neuronal activity (Wu et al., 2002; Ueno et al., 
2013) or SNA (Bhandare et al., 2015) and any possible effect is nullified with 
inclusion of control group. 
Cardiovascular autonomic dysfunction with profound arrhythmogenic effects, 
including prolongation of QT interval, QT dispersion, “T”-wave inversion, and 
tachycardia or bradycardia, are major risks for SUDEP in humans and animals with 
spontaneous recurrent seizures (Opherk et al., 2002; Sakamoto et al., 2008; Metcalf 
et al., 2009; Brotherstone et al., 2010; Powell et al., 2014b; Eastaugh et al., 2015; 
Lamberts et al., 2015). Activated microglia are present in post-SE rats (Shapiro et al., 
2008), and during chronic periods of epilepsy in humans (Beach et al., 1995) and 
animals (Shapiro et al., 2008). Our electrophysiology findings suggest that during 
chronic epilepsy ramified or activated microglia (“M1” phenotype) might have 
produced pro-inflammatory cytokines, and contributed to a persistent 
neuroinflammation that lead to higher SNA and prolongation of QT interval (Fig. 9), 
which was seen even one hour after spontaneous seizure. However, microglial 
morphological analysis revealed no change in their phenotype at least in the vicinity 
of the RVLM neurons. In this paradigm, as shown recently, physiological stimulus 
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alert microglia (ramified) (Vinet et al., 2012), and change their spatial distribution and 
extent of end point processes contacting synapses without significant morphological 
changes (Kapoor et al., 2016c), which might be facilitating the pro-inflammatory 
effects during chronic epilepsy. Microglial activation into a deleterious phenotype in 
Parkinson’s disease is responsible for chronic neuroinflammation, and progressive 
neurodegeneration of dopaminergic neurons (Gao et al., 2011). Thus, increased 
microglial activation or alertness during the post-seizure period in chronic epilepsy 
might mediate the expression and release of pro-inflammatory cytokines, and 
neuroinflammation in the IML. This might lead to severe cardiovascular autonomic 
dysfunction and a higher risk of malignant cardiac arrhythmias, and SUDEP, during 
chronic epilepsy (Fig. 9) (Kloster and Engelskjøn, 1999; Langan et al., 2000). 
Moreover, deleterious microglial response during chronic epilepsy might regulate the 
neurodegeneration, and neuronal loss in brainstem autonomic nuclei in SUDEP and 
TLE patients (Mueller et al., 2014). Collectively, chronic epilepsy-induced microglial 
activation contributes to sympathoexcitation and severe arrhythmogenic changes in 
rats. 
PACAP is a pleiotropic neuropeptide that achieves its effect through cAMP-mediated 
mechanisms. PACAP produces neuroprotective effects (Shioda et al., 1998) as well 
as activates sympathetic efferent neurons (Farnham et al., 2008; Farnham et al., 
2011; Inglott et al., 2011). Antagonism of PACAP in the IML during acute seizures 
cause greater sympathoexcitation in rats (Bhandare et al., 2015), suggesting its 
neuroprotective effect during acute seizures. Microinjection of a PACAP receptor 
antagonist into the RVLM during acute seizures does not alter SNA but does 
ameliorate the seizure-induced arrhythmogenic effects (Bhandare et al., 2016a). Our 
results demonstrate that antagonism of PACAP at the IML during chronic epilepsy 
did not alter SNA or QTc interval, which suggests that PACAP is not modulating 
overall sympathetic output or arrhythmogenic effects in chronic epileptic rats. This 
might be due to low levels of PACAP in post-SE rats under our experimental 
conditions. PACAP gene expression increases after seizures, and reaches maximum 
at 12 h (Fig. 9) (Nomura et al., 2000). During electrophysiology experiments, we did 
not observe spontaneous seizures, which suggest that there might not be increased 
PACAP levels in post-SE rats during electrophysiology recordings. However, 
expression of PACAP can be upregulated after-seizures during the chronic epilepsy, 
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which could produce either neuroprotective or excitatory effect on sympathetic 
preganglionic neurons as shown previously (Farnham et al., 2008; Farnham et al., 
2011; Bhandare et al., 2015; Bhandare et al., 2016b; Bhandare et al., 2016a). 
Cardiovascular reflexes (baroreflex, somatosympathetic-reflex and peripheral and 
central chemoreflex) are crucial for regulation of arterial blood pressure, blood pH, 
and its chemical constituents (glucose, PaCO2 etc.) (Pilowsky and Goodchild, 2002; 
Shahid et al., 2011). The baroreflex is the first line of defence during changes in 
blood pressure and is impaired in epilepsy patients, and animal models (Sakamoto et 
al., 2005; Dütsch et al., 2006). Glutamate is a major excitatory neurotransmitter, and 
responsible for normal maintenance of reflex responses (Miyawaki et al., 1996; 
Pilowsky and Goodchild, 2002; Pilowsky et al., 2009), which also plays an important 
role in the development of seizure (Casillas-Espinosa et al., 2012; Powell et al., 
2014a; Bhandare et al., 2016b). Heart-rate baroreflex sensitivity decreases with 
intracerebroventricular injection of PACAP in trout  (Lancien et al., 2011), whereas in 
rats, PACAP agonist or antagonist microinjection into the RVLM produce no 
significant effect (Farnham et al., 2012). In spontaneously hypertensive rats, 
increased microglial activation, and pro-inflammatory cytokines in PVN causes 
autonomic (baroreflex) dysfunction (Masson et al., 2015). However, our findings 
show that neither PACAP nor microglia antagonist affect the baroreflex, peripheral or 
central chemoreflex response in epileptic or control rats. In control rats, the microglia 
antagonist decreases the fast conducting, A-fibre, somatosympathetic response, 
whereas the PACAP antagonist decreases the slow conducting C-fibre 
somatosympathetic response; none of the antagonist treatments have effects in 
epileptic rats. The PACAP antagonist response is consistent with our other findings 
where PACAP(6-38) treatment did not alter the SNA and ECG findings in chronic 
epileptic or control rats. 
Seizure activity is accompanied with increased sympathetic output, increased plasma 
noradrenaline levels, tachycardia and elevated blood pressure (Read et al., 2015; 
Bhandare et al., 2016a). However, our non-invasive blood pressure measurements 
and plasma catecholamine analysis did not reveal significant differences in MAP or 
plasma catecholamine levels interictally between epileptic and control rats. In 
epileptic rats, plasma catecholamine levels are reported to peak at 48 h post-seizure 
and then return to normal (Read et al., 2015). Differences in species, model, seizure 
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type, seizure frequency, and duration might explain the non-significant differences in 
MAP and plasma catecholamines seen in epileptic and control rats. 
Sudden cardiac death in chronic epilepsy (Kloster and Engelskjøn, 1999; Langan et 
al., 2000) as well as cardiorespiratory autonomic dysfunction (So et al., 2000; Opherk 
et al., 2002; Seyal et al., 2010) is almost always associated with seizures. Therefore, 
it is quite likely that activated microglia-mediated neuroinflammatory changes 
occurring after seizure are major contributors in central autonomic cardiorespiratory 
dysfunction, and potentially SUDEP (Fig. 9). Overall, the current findings suggest that 
spontaneous recurrent seizures in chronically epileptic rats produce tachycardia with 
long-term prolongation of QT interval. Microglial activation in the IML contributes to 
higher SNA and arrhythmogenic effects in chronic epileptic rats. These findings will 
help to understand the biphasic microglial response at different stages in epilepsy, 
and assist in tailoring treatment strategies for seizure-induced central autonomic 
cardiovascular dysfunction with potential implications to reduce the risk of SUDEP in 
patients with chronic epilepsy.  
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Legends: 
Figure 1: In vivo effects of IT minocycline treatment in post-SE rat on cardiovascular 
reflex responses. A typical response of stimulation of aortic depressor nerve (ADN) 
(B), sciatic nerve (SN) (C), peripheral chemoreceptors (D) and central 
chemoreceptors (E) on the SNA and on HR, end-tidal CO2, blood pressure, EEG and 
SNA activity (A). The protocol was repeated at 60, and/or 90 and 120 min after IT 
treatment. 
Figure 2: A typical spontaneous recurrent seizure (top) with a transition into ictal 
period (bottom) in epileptic rat. 
Figure 3: The spontaneous seizure-induced tachycardia and heart rate variability. 
The effect of spontaneous seizure on HR (A) during in vivo EEG-ECG recordings in 
post-SE rat. The spontaneous seizure produced significant tachycardia along with 
increased variability in HR (B-E) during post-ictal period. 
Figure 4: In vivo effects of IT PBS, PACAP(6-38) and minocycline treatment in post-
SE and control rats. Change in SNA (AUC) between 60 and 120 min post treatment 
in post-SE (AI) and control (BI) rats. The changes in MAP (mmHg) at 120 min post IT 
treatment in post-SE (AII) and control (BII) rats, and HR (bpm) at 120 min after IT 
treatment in post-SE (AIII) and control (BIII) rats. Statistical significance was 
determined using one-way ANOVA followed by t-tests with a Holm Šídák correction. 
Data expressed as mean ± SEM. *p ≤ 0.05 compared with IT PBS treated post-SE 
group. 
Figure 5: In vivo effects of IT PBS, PACAP(6-38) and minocycline treatment on ECG 
activity. Group data showing effect of IT PBS, PACAP(6-38) and minocycline 
treatment on: changes in corrected QT interval (∆ QTc) (ms) (AI) and PR interval (∆ 
PR) (ms) (AII) at 120 min post treatment compared to the pre-treatment period in 
post-SE rats; and changes in QTc interval (∆ QTc) (ms) (BI) and PR interval (∆ PR) 
(ms) (BII) at 120 min post treatment compared to the pre-treatment period in control 
rats. Representative Poincare plots illustrate changes in QT interval in post-SE rats 
from three different groups treated with IT PBS (CI), PACAP(6-38) (CII) and 
minocycline (CIII). IT PBS (CI) and PACAP(6-38) (CII) treatment in post-SE rats does 
not alter the QT interval, whereas antagonism of microglial activity significantly 
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reduces the QT interval (CIII) in post-SE rats. Statistical significance was determined 
using one-way ANOVA followed by t-tests with a Holm Šídák correction. Data 
expressed as mean ± SEM. *p ≤ 0.05 compared with IT PBS treated post-SE group. 
Figure 6: In vivo effects of IT PBS, PACAP(6-38) and minocycline treatment on 
baroreflex and somatosympathetic reflex responses in post-SE and control rats. The 
% change in baroreflex response at 60, 90 and 120 min post IT treatment compared 
to pre-treatment period in post-SE (AI) and control rats (BI). Effect of IT treatment on 
% change in fast conducting (A-fibre) somatosympathetic response at 60, 90 and 120 
min post treatment compared to pre-treatment period in post-SE (AII) and control 
(BII) rats. The % change in slow conducting (C-fibre) somatosympathetic response at 
60, 90 and 120 min post IT treatment compared to pre-treatment period in post-SE 
(AIII) and control (BIII) rats. Statistical significance was determined using one-way 
ANOVA followed by t-tests with a Holm Šídák correction. Data expressed as mean ± 
SEM. *p ≤ 0.05 compared with the pre-treatment time-point in post-SE group. ###p ≤ 
0.001, ##p ≤ 0.01, #p ≤ 0.05 compared with the pre-treatment time-point in control 
group. 
Figure 7: In vivo effects of IT PBS, PACAP(6-38) and minocycline treatment on 
peripheral and central chemoreflex responses in post-SE and control rats. The % 
change in peripheral (AI) and central (AII) chemoreflex response at 60 and 120 min 
post IT treatment compared to pre-treatment period in post-SE rats. The % change in 
peripheral (BI) and central (BI) chemoreflex response at 60 and 120 min post IT 
treatment compared to pre-treatment period in control rats. Statistical significance 
was determined using one-way ANOVA followed by t-tests with a Holm Šídák 
correction. Data expressed as mean ± SEM. 
Figure 8: Fluorescence images of the RVLM area containing TH+-ir (red), Iba-1 
labelled microglia (yellow) and CD206-labelled M2 microglial cells (green) in post-SE 
(A) and control (B) rats. Scale bar, 20 µm. In both groups TH+-ir neurons (red) were 
surrounded with microglia with its round cell body and normal appearing processes 
with few ramifications (closed arrow) and no change in number of anti-inflammatory 
M2 microglia (open arrow). 
Figure 9: A proposed mechanism of action of microglia and PACAP on sympathetic 
neurons at the IML during acute and chronic seizures, and its possible outcomes. 
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Time scale on x-axis is variable from hours to days. Under normal conditions, highly 
motile “surveilling” microglia continuously survey their microenvironment through 
direct contact with neuronal synapses and exchange molecular signals. Microglia can 
immediately sense the disturbed functional and structural integrity of neurons during 
conditions, such as seizures. Upon detection of these trigger that are higher than the 
activation threshold, microglia respond through reorganisation of their processes and 
activity profile. During acute seizures, microglia might acquire “beneficial” activation 
state (M2) and produce neurotropic factors, such as IL-10 and TGF-β, to protect the 
overexcited neurons, and limit further damage and restore normal homeostatic 
condition. Seizure also triggers synthesis and release of PACAP, which peaks at 12 
h post seizure, and produce either neuroprotective or excitatory effects on 
sympathetic neurons at IML. However, chronic seizures may trigger more drastic 
changes in functional phenotype of microglia. During chronic seizures, maladaptive 
responses of microglia may lead to “deleterious” activation state (M1) that triggers 
release of inflammatory molecules such as IL-1β and TNFα. This could be the 
mechanism for increased risk of SUDEP during chronic phase of epilepsy, and 
specifically during post-seizure period (as shown in orange) that is associated with 
central autonomic cardiovascular dysfunctions such as increased SNA and 
proarrhythmogenic changes. 
Table 1: Spontaneous seizure frequency and duration in post-SE chronic epileptic 
rats. Seizure frequency and duration per day in IT PBS, PACAP(6-38) and 
minocycline treated post-SE rats. In each group n = 5. Data expressed as mean ± 
SEM. 
Table 2: The cardiovascular activity and catecholamine levels in post-SE chronic 
epileptic rats compared to control. MAP (mmHg) and HR (bpm) in post-SE, and 
control rats recorded under conscious conditions. Plasma adrenaline (nmol/L) and 
noradrenaline (nmol/L) concentration in post-SE and control group of rats. Statistical 
significance was determined using unpaired t-test. Data expressed as mean ± SEM. 
Table 3: Morphological analysis of fluorescence images of the RVLM area containing 
TH+-ir, Iba-1 labelled microglia and CD206-labelled M2 microglial cells in post-SE 
and control rats. In both groups, there are no changes in number of Iba-1 labelled 
  
33 
 
microglia, number of anti-inflammatory M2 microglia or their morphology. Data 
expressed as mean ± SEM. 
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Table 1: 
Post SE + IT PBS 
Animal No. 1 2 3 4 5 
No. of 
seizures/day 
0.29 ± 0.18 0.50 ± 0.50 # 0.43 ± 0.20 # 
Seizure duration 
(sec)/ day 
13.57 ± 8.87 20.50 ± 20.50 # 21.71  ± 10.36 # 
Post SE + IT PACAP (6-38) 
Animal No. 1 2 3 4 5 
No. of 
seizures/day 
1.00 ± 0.53 0.71 ± 0.29 0.50 ± 0.50 0.57 ± 0.30 0.17 ± 0.17 
Seizure duration 
(sec)/ day 
44.71 ± 24.34 30.29 ± 12.74 25.0 ± 25.0 33.57 ± 16.89 5.0 ± 5.0 
Post SE + IT Minocycline 
Animal No. 1 2 3 4 5 
No. of 
seizures/day 
0.86 ± 0.26 0.71 ± 0.18 0.14  ± 0.14 # 0.43 ± 0.20 
Seizure duration 
(sec)/ day 
31.14 ± 9.27 26.14 ± 7.16 4.57 ± 4.57 # 24.43 ± 12.39 
# Seizures were not detected in the rat during the recording period. 
Table 2: 
Treatment group Post-SE Control 
MAP (mmHg) 125.80 ± 4.49 129.3 ± 3.9 
HR (bpm) 310 ± 8 326 ± 10 
Adrenaline (nmol/L) 1.58 ± 0.31 1.9 ± 0.49 
Noradrenaline (nmol/L) 3.38 ± 0.51 3.93 ± 0.78 
 
Table 3: 
Treatment group Post-SE Control 
No. of microglia 241 233 
No. of end processes/microglia 403 ± 76 478 ± 122 
Branch length (µm)/microglia 197.60 ± 5.69 224.90 ± 12.24 
% CD206 labelled microglia 12.91 ± 3.95 8.89 ± 2.14 
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Highlights: 
 Epilepsy-induced altered cardiovascular function, regulated by autonomic 
nervous system, is a major cause of death. 
 Chronic spontaneous seizures in rats produce profound proarrhythmogenic 
effects. 
 In epileptic rats, proarrhythmogenic and sympathoexcitatory effects are 
mediated by action of microglia at spinal cord. 
 Neither PACAP nor microglia regulate the major cardiovascular reflex 
responses in epileptic rats. 
 Modifying the microglial activity in epileptics might produce 
sympathoprotective and eventually cardioprotective effects. 
 
 
 
